A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus for our current fight.
Author: Stephanie Nolen
In Southern Africa, Success Against H.I.V. Offers Hope for Beating Back Another Virus
A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus for our current fight.
Most of the World’s Vaccines Likely Won’t Prevent Infection From Omicron
They do seem to offer significant protection against severe illness, but the consequences of rapidly spreading infection worry many public health experts.
A Times correspondent returning from South Africa got caught up in the chaotic response to Omicron.
The Omicron variant turned my trip home from South Africa into a nightmare episode of conflicting public health orders that often seemed to have little connection to science.
How Conflicting Guidance on Travel During the Pandemic Shows Little Progress
The Omicron variant turned my trip home from South Africa into a nightmare episode of conflicting public health orders that often seemed to have little connection to science.
As Vaccines Trickle Into Africa, Zambia’s Challenges Highlight Other Obstacles
Vaccinating Africa is critical to protecting the continent and the world against dangerous variants, but supply isn’t the only problem countries face.
The Variant Hunters: Inside South Africa’s Effort to Stanch Dangerous Mutations
Scientists in a cutting-edge laboratory do part of the work. Local health workers on foot do the rest.
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.